Derek Gregory Batcheller
Chairman chez XINTELA AB
Profil
Mr. Derek Gregory Batcheller is a Chairman at Xintela AB, a Chief Executive Officer at Stanbridge Corp.
BV, a Chairman at CarryGenes Therapeutics AB, a Chairman at Intellego Technologies AB, a Chairman at Lundoch Diagnostics AB, a Chairman at SAGA Diagnostics AB, a Chairman at Targinta AB, an Executive Chairman at ImmuneBiotech Medical Sweden AB and a Partner at Aqilion AB.
He is on the Board of Directors at Business Research Life Sciences Ltd., CanImGuide Therapeutics AB and Immodulate Pharma AB.
Mr. Batcheller was previously employed as a Chairman by AcuCort AB, a Chairman by Preelumina AB, a Chairman by Preelumina Diagnostics AB, a Chairman by Guard Therapeutics International AB, a Co-Founder by Laccure AB, an Executive Chairman by NeuroVive Pharmaceutical AB, a Chairman by Monocl AB, a Chief Executive Officer by Pulsetten AB, and a Co-Founder by Trophea AB.
He also served on the board at Dermafol AB, Maas Biolab LLC and OVB Freehold Ltd.
He received his undergraduate degree from London School of Economics & Political Science, a graduate degree from the University of Lund and a graduate degree from the University of Toronto.
Postes actifs de Derek Gregory Batcheller
| Sociétés | Poste | Début |
|---|---|---|
| XINTELA AB | Chairman | 01/01/2011 |
| INTELLEGO TECHNOLOGIES AB | Chairman | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | - |
| Lundoch Diagnostics AB | Chairman | - |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Chairman | - |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Chairman | - |
| Immodulate Pharma AB | Director/Board Member | - |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Chairman | - |
| ░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Derek Gregory Batcheller
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
Formation de Derek Gregory Batcheller
| University of Toronto | Graduate Degree |
| London School of Economics & Political Science | Undergraduate Degree |
| University of Lund | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ABLIVA AB | Health Technology |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| XINTELA AB | Health Technology |
| ACUCORT AB | Health Technology |
| INTELLEGO TECHNOLOGIES AB | Electronic Technology |
| Entreprise privées | 19 |
|---|---|
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
Maas Biolab LLC
 Maas Biolab LLC Pharmaceuticals: MajorHealth Technology Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation. | Health Technology |
Dermafol AB
 Dermafol AB Medical/Nursing ServicesHealth Services Dermafol AB develops treatment for skin and mucus membranes diseases. It engages in the development and commercialization of unique, folate based therapies in certain specific areas mainly the mucous membranes. It also offers cancer research services. The company is headquartered in Göteborg, Sweden | Health Services |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
| Stanbridge Corp. BV | |
| Preelumina Diagnostics AB | |
Monocl AB
 Monocl AB Internet Software/ServicesTechnology Services Monocl AB develops cloud-based stakeholder platform. Its areas include business development, valuation, and communication. The company was founded by Björn Carlsson and Tobias Thornblad in 2011 and is headquartered in Gothenburg, Sweden. | Technology Services |
| Pulsetten AB | |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Health Services |
| Business Research Life Sciences Ltd. | |
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Commercial Services |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Health Technology |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Health Technology |
CarryGenes Therapeutics AB
CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Commercial Services |
| OVB Freehold Ltd. | |
| Immodulate Pharma AB | |
| Lundoch Diagnostics AB | |
Preelumina AB
 Preelumina AB Pharmaceuticals: MajorHealth Technology PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden. | Health Technology |
